Stephen Sheldon

Chief Financial Officer, Kuvatris Therapeutics, Inc.

Companies

Kuvatris Therapeutics, Inc.Chief operating officer Nov 22, 2023 to Mar 14, 2024¹
Kuvatris Therapeutics, Inc.Chief financial officer Aug 12, 2022 to Mar 14, 2024²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Kuvatris Therapeutics, Inc.11,243 shares³Mar 14, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 12, 2024Shares withheld for tax 3,356 shares at $0.69 of Kuvatris Therapeutics, Inc.³
Feb 21, 2024Shares withheld for tax 243 shares at $0.66 of Kuvatris Therapeutics, Inc.⁴
Nov 20, 2023Shares withheld for tax 971 shares at $1.75 of Kuvatris Therapeutics, Inc.⁵
Apr 13, 2023Granted 100,000 shares of Kuvatris Therapeutics, Inc.⁶
Nov 19, 2022Granted 135,000 shares of Kuvatris Therapeutics, Inc.⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARKuvatris Therapeutics, Inc., Chief operating officer
2
SEC EDGARKuvatris Therapeutics, Inc., Chief financial officer
3
SEC EDGARKuvatris Therapeutics, Inc. shares after the filing of Mar 14, 2024
4
SEC EDGARForm 4 filed Feb 23, 2024
5
SEC EDGARForm 4 filed Nov 22, 2023
6
SEC EDGARForm 4 filed Apr 14, 2023
7
SEC EDGARForm 4 filed Nov 22, 2022